Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Feasibility study investigating circulating peripheral mitochondrial DNA as a potential non-invasive biomarker for diagnosis and surveillance of high-risk cutaneous melanoma
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Earlham Institute | Charity Commission: 1136213 Companies House: 06855533 | £87,512 | - |
Government spending data: This supplier has received £11,399,667 in 63 payments (over £25k) from UKRI (2023-01-06 to 2023-06-21). View full payment history →